Reduced Numbers of Corticotropin-Releasing Hormone Neurons in Narcolepsy Type 1.

Publication Year: 2022

DOI:
10.1002/ana.26300

PMCID:
PMC9306683

PMID:
34981555

Journal Information

Full Title: Ann Neurol

Abbreviation: Ann Neurol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential Conflicts of Interest L.S., R.F., and G.J.L. have received research support from Jazz Pharma (Solriamfetol is a Jazz Pharma medication used in the treatment of excessive sleepiness) and Bioprojet (Pitolisant, manufactured by Bioprojet, is used in the treatment of narcolepsy). R.F. and G.J.L. have received consultancy fees from Bioprojet."

Evidence found in paper:

"L.S. has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska‐Curie grant (Agreement No. 707404) and has been awarded the Young Scientist Award 2020 by the European Narcolepsy Network (supported by the Klaus‐Grawe Foundation). D.F.S. and L.S. were supported by Friends of the Netherlands Institute for Neuroscience Foundation. This work was partially supported by research grants from the Bioprojet‐Biotech, Saint Gregoire, France. The funding agencies had no role in the design of the study, nor in the collection, analysis, or interpretation of data."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025